Page 3 - Surescreen Diagnostics News Today

MATT HANCOCK: We begin 2021 knowing that vaccines are our way out of this pandemic. Human ingenuity and phenomenal scientific advances make it a case of when, not if, we will return to normal life.

Date Time UK Government to deploy first British-manufactured rapid lateral flow antigen tests for COVID-19 The Government has ordered two million of the first British-manufactured rapid lateral flow antigen tests for COVID-19 to be validated by Public Health England, for use in asymptomatic testing, Health and Social Care Secretary Matt Hancock has announced. Derby-based company SureScreen Diagnostics is to provide two million of the lateral flow tests, which provide results in under 30 minutes...

Secretary of State for Health and Social Care shares thoughts on vaccines, testing and the R number.

10 January 2021 The government has ordered 2 million of the first British-manufactured rapid lateral flow antigen tests for COVID-19 to be validated by Public Health England, for use in asymptomatic testing, Health and Social Care Secretary Matt Hancock has announced. Derby-based company SureScreen Diagnostics is to provide 2 million of the lateral flow tests, which provide results in under 30 minutes, by next Friday (15 January), with the potential to provide millions more in the coming months...

The Government has ordered two million of the first British-manufactured rapid lateral flow antigen tests for Covid-19 to be validated by Public Health England, for use in asymptomatic testing.

Share: New York, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "COVID-19 Diagnostics Market - Global Outlook and Forecast 2021-2026" - https://www.reportlinker.com/p05995439/?utm_source=GNW The RT-PCR testing segment constituted over 75% of the global COVID diagnostics market share. The market is growing because of the outbreak of the coronavirus (SARS CoV-2) pandemic, which has increased the demand for rapid testing across the world. As the number of ...

| Press Release The global COVID-19 diagnostics market by revenue is expected to register a negative CAGR of (9%) during the period 2021–2026 New York, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "COVID-19 Diagnostics Market - Global Outlook and Forecast 2021-2026" - https://www.reportlinker.com/p05995439/?utm_source=GNW The RT-PCR testing segment constituted over 75% of the global COVID diagnostics market share. The market is growing because of...